Issued Patents All Time
Showing 26–50 of 65 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11969475 | Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy | Mohammed T. Qatanani, Timothy Weeden, Cody A. Desjardins, Brendan Quinn, John Najim | 2024-04-30 |
| 11931421 | Muscle targeting complexes and formulations for treating myotonic dystrophy | Scott A. Hilderbrand, Timothy Weeden, John Najim, Stefano Zanotti, Mohammed T. Qatanani +3 more | 2024-03-19 |
| 11911484 | Muscle targeting complexes and uses thereof for treating myotonic dystrophy | Mohammed T. Qatanani, Timothy Weeden, Cody A. Desjardins | 2024-02-27 |
| 11844843 | Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy | Mohammed T. Qatanani, Timothy Weeden, Cody A. Desjardins, Brendan Quinn, John Najim | 2023-12-19 |
| 11839660 | Anti-transferrin receptor antibody and uses thereof | Mohammed T. Qatanani, Timothy Weeden, Cody A. Desjardins, Brendan Quinn, John Najim | 2023-12-12 |
| 11833217 | Muscle targeting complexes and uses thereof for treating dystrophinopathies | Mohammed T. Qatanani, Timothy Weeden | 2023-12-05 |
| 11795233 | Muscle-targeting complex comprising an anti-transferrin receptor antibody linked to an oligonucleotide | Mohammed T. Qatanani, Timothy Weeden | 2023-10-24 |
| 11795234 | Methods of producing muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide | Mohammed T. Qatanani, Timothy Weeden | 2023-10-24 |
| 11787869 | Methods of using muscle targeting complexes to deliver an oligonucleotide to a subject having facioscapulohumeral muscular dystrophy or a disease associated with muscle weakness | Mohammed T. Qatanani, Timothy Weeden | 2023-10-17 |
| 11788089 | Compositions and methods for modulating MECP2 expression | Arthur M. Krieg, James McSwiggen, Jeannie T. Lee | 2023-10-17 |
| 11771776 | Muscle targeting complexes and uses thereof for treating dystrophinopathies | Mohammed T. Qatanani, Timothy Weeden, Cody A. Desjardins, Brendan Quinn, John Najim | 2023-10-03 |
| 11759525 | Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy | Mohammed T. Qatanani, Timothy Weeden, Cody A. Desjardins, Brendan Quinn, John Najim | 2023-09-19 |
| 11679161 | Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy | Mohammed T. Qatanani, Timothy Weeden, Cody A. Desjardins, Brendan Quinn, John Najim | 2023-06-20 |
| 11672872 | Anti-transferrin receptor antibody and uses thereof | Mohammed T. Qatanani, Timothy Weeden, Cody A. Desjardins, Brendan Quinn, John Najim | 2023-06-13 |
| 11648318 | Anti-transferrin receptor (TFR) antibody and uses thereof | Mohammed T. Qatanani, Timothy Weeden, Cody A. Desjardins, Brendan Quinn, John Najim | 2023-05-16 |
| 11638761 | Muscle targeting complexes and uses thereof for treating Facioscapulohumeral muscular dystrophy | Mohammed T. Qatanani, Timothy Weeden, Cody A. Desjardins, Brendan Quinn, John Najim | 2023-05-02 |
| 11633496 | Muscle targeting complexes and uses thereof for treating dystrophinopathies | Mohammed T. Qatanani, Timothy Weeden | 2023-04-25 |
| 11633498 | Muscle targeting complexes and uses thereof for treating myotonic dystrophy | Mohammed T. Qatanani, Timothy Weeden, Cody A. Desjardins, Brendan Quinn, John Najim | 2023-04-25 |
| 11518816 | Methods of delivering an oligonucleotide to a subject having facioscapulohumeral muscular dystrophy | Mohammed T. Qatanani, Timothy Weeden | 2022-12-06 |
| 11497815 | Muscle targeting complexes and uses thereof for treating dystrophinopathies | Mohammed T. Qatanani, Timothy Weeden | 2022-11-15 |
| 11389546 | Heterologous UTR sequences for enhanced mRNA expression | David H. Burkhardt, Christian Cobaugh | 2022-07-19 |
| 11390682 | Methods of intravenouisly delivering anti-transferrin antibody/oligonucleotide complexes to subjects having muscular dystrophy | Mohammed T. Qatanani, Timothy Weeden | 2022-07-19 |
| 11369689 | Muscle targeting complexes and uses thereof for treating dystrophinopathies | Mohammed T. Qatanani, Timothy Weeden | 2022-06-28 |
| 11286305 | Complex comprising anti-transferrin receptor antibody covalently linked to an oligonucleotide that targets DUX4 RNA | Mohammed T. Qatanani, Timothy Weeden | 2022-03-29 |
| 11248056 | Muscle targeting complexes and uses thereof for treating dystrophinopathies | Mohammed T. Qatanani, Timothy Weeden | 2022-02-15 |